Next Article in Journal
Novel 11-Substituted Ellipticines as Potent Anticancer Agents with Divergent Activity against Cancer Cells
Next Article in Special Issue
CDK8-Novel Therapeutic Opportunities
Previous Article in Journal
Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13
Previous Article in Special Issue
CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
 
 
Article

Article Versions Notes

Pharmaceuticals 2019, 12(2), 89; https://doi.org/10.3390/ph12020089
Action Date Notes Link
article xml file uploaded 14 June 2019 09:07 CEST Original file -
article xml uploaded. 14 June 2019 09:07 CEST Update https://www.mdpi.com/1424-8247/12/2/89/xml
article pdf uploaded. 14 June 2019 09:07 CEST Version of Record https://www.mdpi.com/1424-8247/12/2/89/pdf
article html file updated 14 June 2019 09:09 CEST Original file -
article html file updated 5 July 2019 07:59 CEST Update -
article html file updated 5 July 2019 13:38 CEST Update -
article html file updated 21 October 2019 21:11 CEST Update -
article html file updated 12 February 2020 19:39 CET Update -
article html file updated 20 July 2022 15:36 CEST Update https://www.mdpi.com/1424-8247/12/2/89/html
Back to TopTop